公司资料
Puma Biotechnology Inc 股价、新闻与催化剂
- 股票代码:
- PBYI
- 交易所:
- NASDAQ
- 行业:
- Biopharma
- 所在地:
- United States
股票表现
8.82 USD (-0.11%)
收盘价
最后更新: 2026年8月17日
355M USD
市值
股价为何变动
As of Aug 17, 2026, PBYI was little changed and closed at $8.82. No new same-company headline was identified in the current news window.
公司概览
业务概览
Puma Biotechnology is an oncology company focused on breast-cancer therapy and targeted cancer medicines. Its business has long centered on a concentrated commercial oncology franchise.
所在地与行业分类
Headquartered in the United States and listed on NASDAQ, Puma sits in specialty oncology biotechnology.
商业模式特征
The company depends on product revenue, market access, and the durability of its commercial cancer portfolio.
生物医药行业定位
Puma is a commercial oncology name with limited breadth but meaningful sensitivity to product execution.
未来催化剂
- Puma Biotechnology’s catalysts are NERLYNX execution and any label / oncology update that extends the franchise. Investors will care about whether the commercial base can keep hanging on.
近期新闻
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。